drugset / Trial / NCT01247818
Randomized Study of PH-10 for Psoriasis
RandomizedParallel-groupSingle-blindTreatment
Summary
PH-10 is an aqueous hydrogel formulation of rose bengal disodium (RB) for topical administration to the skin, and is being studied for the treatment of cutaneous skin disorders, specifically psoriasis and atopic dermatitis. This multicenter phase 2 study of subjects randomized sequentially by center to one of four treatment cohorts will assess efficacy and safety of topical PH-10 applied once daily to areas of mild to moderate plaque psoriasis.
Timeline
- Start
- 2010-12
- Primary completion
- 2011-08
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rose bengal disodium | Unknown | 0.002 % | Topical |
| Subject | rose bengal disodium | Unknown | 0.005 % | Topical |
| Subject | rose bengal disodium | Unknown | 0.01 % | Topical |